IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL R VAUGHN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Addiction Psychiatry

NPI
1598889420
CMS profile
208499
Location
DECATUR, GA

General Payments · PY2018–2024

$6,239.95

  • Reported across 357 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,003.22

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Addiction Psychiatry GA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,003.22 53

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $361.81 19
Takeda Pharmaceuticals U.S.A., Inc. $156.24 9
Lundbeck LLC $91.93 5
Neurocrine BioSciences, Inc. $82.96 3
Otsuka America Pharmaceutical, Inc. $55.17 3
Teva Pharmaceuticals USA, Inc. $54.06 3
ITI, Inc. $44.56 2
Vanda Pharmaceuticals Inc. $35.66 2
IDORSIA PHARMACEUTICALS US INC $34.04 2
Janssen Pharmaceuticals, Inc $29.72 2
Axsome Therapeutics, Inc. $20.62 1
Orexo US, Inc. $19.54 1
E.R. Squibb & Sons, L.L.C. $16.91 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,003.85 64
PY2019 $734.76 41
PY2020 $210.68 13
PY2021 $828.00 48
PY2022 $993.51 60
PY2023 $1,465.93 78
PY2024 $1,003.22 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.89 01/09/2024 Food and Beverage Undisputed 01/23/2026 1106274888 CMS
ABBVIE INC. $13.80 01/17/2024 Food and Beverage Undisputed 01/23/2026 1106274890 CMS
ABBVIE INC. $29.47 02/06/2024 Food and Beverage Undisputed 01/23/2026 1106274892 CMS
ABBVIE INC. $17.91 03/06/2024 Food and Beverage Undisputed 01/23/2026 1106274894 CMS
ABBVIE INC. $24.75 03/19/2024 Food and Beverage Undisputed 01/23/2026 1106274896 CMS
ABBVIE INC. $28.28 03/19/2024 Food and Beverage Undisputed 01/23/2026 1106274898 CMS
ABBVIE INC. $27.63 04/02/2024 Food and Beverage Undisputed 01/23/2026 1106274900 CMS
ABBVIE INC. $31.98 04/10/2024 Food and Beverage Undisputed 01/23/2026 1106274902 CMS
ABBVIE INC. $13.54 04/25/2024 Food and Beverage Undisputed 01/23/2026 1106274904 CMS
ABBVIE INC. $22.70 05/13/2024 Food and Beverage Undisputed 01/23/2026 1106274906 CMS
ABBVIE INC. $17.17 06/05/2024 Food and Beverage Undisputed 01/23/2026 1106274908 CMS
ABBVIE INC. $22.87 07/03/2024 Food and Beverage Undisputed 01/23/2026 1106274910 CMS
ABBVIE INC. $19.64 08/07/2024 Food and Beverage Undisputed 01/23/2026 1106274912 CMS
ABBVIE INC. $2.59 08/14/2024 Food and Beverage Undisputed 01/23/2026 1106274914 CMS
ABBVIE INC. $17.02 08/27/2024 Food and Beverage Undisputed 01/23/2026 1106274916 CMS
ABBVIE INC. $8.72 10/01/2024 Food and Beverage Undisputed 01/23/2026 1106274918 CMS
ABBVIE INC. $12.84 10/08/2024 Food and Beverage Undisputed 01/23/2026 1106274920 CMS
ABBVIE INC. $20.68 11/06/2024 Food and Beverage Undisputed 01/23/2026 1106274922 CMS
ABBVIE INC. $8.33 12/03/2024 Food and Beverage Undisputed 01/23/2026 1106274924 CMS
Axsome Therapeutics, Inc. $20.62 12/09/2024 Food and Beverage Undisputed 01/23/2026 1148305696 CMS
E.R. Squibb & Sons, L.L.C. $16.91 11/06/2024 Food and Beverage Undisputed 01/23/2026 1101330272 CMS
IDORSIA PHARMACEUTICALS US INC $19.08 01/10/2024 Food and Beverage Undisputed 01/23/2026 1146760275 CMS
IDORSIA PHARMACEUTICALS US INC $14.96 10/31/2024 Food and Beverage Undisputed 01/23/2026 1146792370 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.57 05/15/2024 Food and Beverage Undisputed 01/23/2026 1143338464 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.99 08/07/2024 Food and Beverage Undisputed 01/23/2026 1143338467 CMS
Janssen Pharmaceuticals, Inc $16.54 10/17/2024 Food and Beverage Undisputed 01/23/2026 1077991182 CMS
Janssen Pharmaceuticals, Inc $13.18 12/19/2024 Food and Beverage Undisputed 01/23/2026 1077991094 CMS
Lundbeck LLC $15.99 02/21/2024 Food and Beverage Undisputed 01/23/2026 1145977965 CMS
Lundbeck LLC $20.38 03/20/2024 Food and Beverage Undisputed 01/23/2026 1145977967 CMS
Lundbeck LLC $21.72 05/31/2024 Food and Beverage Undisputed 01/23/2026 1145977969 CMS
Lundbeck LLC $13.11 11/12/2024 Food and Beverage Undisputed 01/23/2026 1145977971 CMS
Lundbeck LLC $20.73 12/11/2024 Food and Beverage Undisputed 01/23/2026 1145977973 CMS
Neurocrine Biosciences, Inc. $29.56 02/22/2024 Food and Beverage Undisputed 01/23/2026 1150826698 CMS
Neurocrine Biosciences, Inc. $25.54 06/18/2024 Food and Beverage Undisputed 01/23/2026 1150838438 CMS
Neurocrine Biosciences, Inc. $27.86 11/11/2024 Food and Beverage Undisputed 01/23/2026 1150831618 CMS
Orexo US, Inc. $19.54 05/30/2024 Food and Beverage Undisputed 01/23/2026 1136177070 CMS
Otsuka America Pharmaceutical, Inc. $14.43 01/31/2024 Food and Beverage Undisputed 01/23/2026 1118998717 CMS
Otsuka America Pharmaceutical, Inc. $18.49 02/07/2024 Food and Beverage Undisputed 01/23/2026 1118998719 CMS
Otsuka America Pharmaceutical, Inc. $22.25 11/26/2024 Food and Beverage Undisputed 01/23/2026 1118998721 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.61 01/22/2024 Food and Beverage Undisputed 01/23/2026 1137691951 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.79 02/12/2024 Food and Beverage Undisputed 01/23/2026 1137691953 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.18 03/26/2024 Food and Beverage Undisputed 01/23/2026 1137691955 CMS
Takeda Pharmaceuticals U.S.A., Inc. $23.38 04/09/2024 Food and Beverage Undisputed 01/23/2026 1137691957 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.06 05/14/2024 Food and Beverage Undisputed 01/23/2026 1137691959 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.84 06/11/2024 Food and Beverage Undisputed 01/23/2026 1137691961 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.01 07/02/2024 Food and Beverage Undisputed 01/23/2026 1137691963 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.11 08/27/2024 Food and Beverage Undisputed 01/23/2026 1137691965 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.26 11/18/2024 Food and Beverage Undisputed 01/23/2026 1137691967 CMS
Teva Pharmaceuticals USA, Inc. $20.31 01/17/2024 Food and Beverage Undisputed 01/23/2026 1151618148 CMS
Teva Pharmaceuticals USA, Inc. $19.95 03/05/2024 Food and Beverage Undisputed 01/23/2026 1151618164 CMS
Teva Pharmaceuticals USA, Inc. $13.80 09/18/2024 Food and Beverage Undisputed 01/23/2026 1151618214 CMS
Vanda Pharmaceuticals Inc. $15.71 06/19/2024 Food and Beverage Undisputed 01/23/2026 1133924883 CMS
Vanda Pharmaceuticals Inc. $19.95 07/24/2024 Food and Beverage Undisputed 01/23/2026 1133924887 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.